COSENTYX (secukinumab)

**Product type:** Human Prescription Drug

**Active ingredient:** SECUKINUMAB

**Strength:** 300 mg/2mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** BLA (BLA125504)

**Pharmacologic class:** Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]